Literature DB >> 24832737

The genomic complexity underlying pulmonary arterial hypertension: from mendel to networks.

Revathi Rajkumar1, Ferhaan Ahmad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24832737      PMCID： PMC4225853          DOI： 10.1164/rccm.201403-0556ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  18 in total

1.  Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease.

Authors:  Saadia Eddahibi; Ari Chaouat; Li Tu; Christos Chouaid; Emmanuel Weitzenblum; Bruno Housset; Bernard Maitre; Serge Adnot
Journal:  Proc Am Thorac Soc       Date:  2006-08

2.  Angiotensin-converting enzyme gene polymorphisms and prognosis in chronic thromboembolic pulmonary hypertension.

Authors:  Nobuhiro Tanabe; Shinya Amano; Koichiro Tatsumi; Satoshi Kominami; Natsuhiko Igarashi; Ryuhi Shimura; Hiroshi Matsubara; Yasunori Kasahara; Yuichi Takiguchi; Takayuki Kuriyama
Journal:  Circ J       Date:  2006-09       Impact factor: 2.993

Review 3.  The genetic basis of pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  Hum Genet       Date:  2014-01-21       Impact factor: 4.132

4.  Human prostacyclin synthase gene and hypertension : the Suita Study.

Authors:  N Iwai; T Katsuya; K Ishikawa; T Mannami; J Ogata; J Higaki; T Ogihara; T Tanabe; S Baba
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

5.  Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.

Authors:  M W Geraci; B Gao; D C Shepherd; M D Moore; J Y Westcott; K A Fagan; L A Alger; R M Tuder; N F Voelkel
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.

Authors:  Elisabeth D Willers; John H Newman; James E Loyd; Ivan M Robbins; Lisa A Wheeler; Melissa A Prince; Krista C Stanton; Joy A Cogan; James R Runo; Daniel Byrne; Marc Humbert; Gerald Simonneau; Benjamin Sztrymf; Jane A Morse; James A Knowles; Kari E Roberts; Jude J McElroy; Robyn J Barst; John A Phillips
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

Review 7.  Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.

Authors:  Aaron B Waxman; Roham T Zamanian
Journal:  Am J Cardiol       Date:  2013-03-04       Impact factor: 2.778

8.  Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.

Authors:  Carmelle V Remillard; Donna D Tigno; Oleksandr Platoshyn; Elyssa D Burg; Elena E Brevnova; Diane Conger; Ann Nicholson; Brinda K Rana; Richard N Channick; Lewis J Rubin; Daniel T O'connor; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2007-01-31       Impact factor: 4.249

9.  Human gene encoding prostacyclin synthase (PTGIS): genomic organization, chromosomal localization, and promoter activity.

Authors:  C Yokoyama; T Yabuki; H Inoue; Y Tone; S Hara; T Hatae; M Nagata; E I Takahashi; T Tanabe
Journal:  Genomics       Date:  1996-09-01       Impact factor: 5.736

10.  Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.

Authors:  E D Austin; J D Cogan; J D West; L K Hedges; R Hamid; E P Dawson; L A Wheeler; F F Parl; J E Loyd; J A Phillips
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671
View more
  1 in total

Review 1.  Update in Pulmonary Vascular Diseases 2014.

Authors:  Elena A Goncharova; Mark T Gladwin; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.